Novartis
Advertisement
DocWire News recently sat down with Shephard Mpofu, M.D., SVP, Chief Medical Officer, Novartis Gene Therapies, to ...
Pharmaceutical giant Amgen won a ruling in a federal appeals court today against Novartis AG’s Sandoz, preventing the ...
The U.S. Food and Drug Administration (FDA) has expanded the indication of Eli Lilly and Company’s Taltz (ixekizumab) ...
Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about ...
A U.S. judge ruled in favor of Amgen on the validity of two patents pertaining to the company’s drug Enbrel ...
Pear Therapeutics has recently teamed up with Sandoz, a Novartis branch, to release reSET, the first and only ...
This week the Swiss pharmaceutical company Novartis, which has been moving into the rare disease market, said it that ...
The U.S. Food and Drug Administration (FDA) has rejected canakinumab to be used to reduce the risk of cardiovascular ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.